Literature DB >> 3419202

Abortifacient properties of an extract from Sida veronicaefolia.

G D Lutterodt1.   

Abstract

A fraction from an alcoholic extract of Sida veronicaefolia, previously reported to be a potent oxytocic, was studied for its abortifacient effects in pregnant rats. Oral doses producing the abortifacient effects were greater than or equal to 32 ml/kg when administered from the 15th-17th day of pregnancy. Similar effects were produced by intravenous doses of greater than or equal to 3 ml/kg. At the minimum effective oral dose of 32 ml/kg, those animals that carried the conceptuses to term (40%) had litters with reduced average number/litter and weight. At twice this dose, only 10% delivered and the litters were sickly. The effects of intravenous administration of the extract was similar but more pronounced and included also some unique acute effects.

Entities:  

Keywords:  Abortifacient Agents--administraction and dosage; Abortifacient Agents--side effects; Abortion, Drug Induced; Abortion, Induced; Africa; Africa South Of The Sahara; Animals, Laboratory; Biology; Body Weight--changes; Clinical Research; Control Groups; Delivery Of Health Care; Developing Countries; English Speaking Africa; Examinations And Diagnoses; Family Planning; Fertility Control, Postconception; Ghana; Health; Health Services; Laboratory Examinations And Diagnoses; Medicine; Physiology; Plants, Medicinal; Research Methodology; Western Africa

Mesh:

Substances:

Year:  1988        PMID: 3419202     DOI: 10.1016/0378-8741(88)90112-2

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  2 in total

1.  Antidiabetic effect of Sida cordata in alloxan induced diabetic rats.

Authors:  Naseer Ali Shah; Muhammad Rashid Khan
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

2.  Investigation on flavonoid composition and anti free radical potential of Sida cordata.

Authors:  Naseer Ali Shah; Muhammad Rashid Khan; Bushra Ahmad; Farah Noureen; Umbreen Rashid; Rahmat Ali Khan
Journal:  BMC Complement Altern Med       Date:  2013-10-22       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.